YEAR
- 2011.12.05 Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy. Hayashi T, Horiuchi A, Sano K, Hiraoka N, Kasai M, Ichimura T, Sudo T, Tagawa Y, Nishimura R, Ishiko O, Kanai Y, Yaegashi N, Aburatani H, Shiozawa T, Konishi I.Sci Rep. 2011;1:180. doi: 10.1038/srep00180
- 2011.09.03 Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study. Nomura M, Fukuda T, Fujii K, Kawamura T, Tojo H, Kihara M, Bando Y, Gazdar AF, Tsuboi M, Oshiro H, Nagao T, Ohira T, Ikeda N, Gotoh N, Kato H, Marko-Varga G, Nishimura T.J Clin Bioinforma. 2011 Sep 03;1(1):23. doi: 10.1186/2043-9113-1-23
- 2011.01.06 RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway. Wang F, Yamauchi M, Muramatsu M, Osawa T, Tsuchida R, Shibuya M.J. Biol. Chem. 2011 Mar 18;286(11):9097-106. doi: 10.1074/jbc.M110.165605
- 2011.03.01 Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma. Fujiwara M, Kashima TG, Kunita A, Kii I, Komura D, Grigoriadis AE, Kudo A, Aburatani H, Fukayama M.Tumour Biol. 2011 Jun;32(3):611-22. doi: 10.1007/s13277-011-0160-y
- 2011.10.09 Structural basis for the bifunctionality of fructose-1,6-bisphosphate aldolase/phosphatase Fushinobu S, Nishimasu H, Hattori D, Song HJ, Wakagi T.Nature. 2011 Oct 09;478(7370):538-41. doi: 10.1038/nature10457
- 2011.10.23 Suppression of bone formation by osteoclastic expression of semaphorin 4D. Negishi-Koga T, Shinohara M, Komatsu N, Bito H, Kodama T, Friedel RH, Takayanagi H.Nat. Med. 2011 Oct 23;17(11):1473-80. doi: 10.1038/nm.2489
- 2011.06.27 Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs). Yanai H, Chiba S, Ban T, Nakaima Y, Onoe T, Honda K, Ohdan H, Taniguchi T.Proc. Natl. Acad. Sci. U.S.A. 2011 Jul 12;108(28):11542-7. doi: 10.1073/pnas.1108535108
- 2011.10.07 The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice. Suzuki H, Kondoh M, Kakutani H, Yamane S, Uchida H, Hamakubo T, Yagi K.Biomaterials. 2012 Jan;33(1):317-24. doi: 10.1016/j.biomaterials.2011.09.048
CLOSE